ShahAMSolomonSD. Phenotypic and pathophysiological heterogeneity in heart failure with preserved ejection fraction. Eur Heart J2012; 33: 1716–1717.
2.
SharmaKKassDA. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res2014; 115: 79–96.
3.
RozenbaumZTopilskyYKhouryS, et al.Association of body mass index and diastolic function in metabolically healthy obese with preserved ejection fraction. Int J Cardiol2019; 277: 147–152.
4.
PackerMKitzmanDW. Obesity-related heart failure with a preserved ejection fraction: the mechanistic rationale for combining inhibitors of aldosterone, neprilysin, and sodium-glucose cotransporter-2. JACC Heart Fail2018; 6: 633–639.
5.
PadwalRMcAlisterFAMcMurrayJJ, et al.The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond)2014; 38: 1110–1114.
6.
SharmaALavieCJBorerJS, et al.Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol2015; 115: 1428–1434.
7.
World Health Organization. Obesity: preventing and managing the global epidemic; report of a WHO consultation. WHO Tech Rep Ser2000; 894: i–xii; 1–253.
8.
UpadhyaBHaykowskyMJEggebeenJ, et al.Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction. Curr Heart Fail Rep2015; 12: 205–214.
9.
TianSXuY. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr Gerontol Int2016; 16: 155–166.
10.
Campbell DJ, Gong FF, Jelinek MV, et al. Threshold body mass index and sex-specific waist circumference for increased risk of heart failure with preserved ejection fraction. Eur J Prev Cardiol. 2019; 26: 1594–1602.
11.
Van ItersonEHKimCHUithovenK, et al.Obesity and hemoglobin content impact peak oxygen uptake in human heart failure. Eur J Prev Cardiol2018; 25: 1937–1946.
12.
Gorostegi-AnduagaICorresPMartinezAguirre-BetolazaA, et al.Effects of different aerobic exercise programmes with nutritional intervention in sedentary adults with overweight/obesity and hypertension: EXERDIET-HTA study. Eur J Prev Cardiol2018; 25: 343–353.
13.
ZhengSLChanFTNabeebaccusAA, et al.Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Heart2018; 104: 407–415.
14.
NassifMEKosiborodM. Effects of sodium glucose cotransporter type 2 inhibitors on heart failure. Diabetes Obes Metab2019; 21(Suppl. 2): 19–23.